Medicines for Malaria Venture
Project disclaimer
Description
The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health Research (NIHR). The NIHR provided support to the Medicines for Malaria Venture (MMV) to carry out activities relating to the development of new drugs to treat malaria.
Objectives
1) Increase investment in chemoprevention; 2) Develop new fast acting molecules to support treatment of uncomplicated and potentially severe malaria; 3) Develop compounds active against laboratory generated resistant strains and field isolates.
Location
The country, countries or regions that benefit from this Programme.
Status Post-completion
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Extending
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.